LV10626A - Peptidi - Google Patents

Peptidi

Info

Publication number
LV10626A
LV10626A LV930540A LV930540A LV10626A LV 10626 A LV10626 A LV 10626A LV 930540 A LV930540 A LV 930540A LV 930540 A LV930540 A LV 930540A LV 10626 A LV10626 A LV 10626A
Authority
LV
Latvia
Prior art keywords
amino acid
fmdv
sequence
cell
peptide
Prior art date
Application number
LV930540A
Other languages
English (en)
Other versions
LV10626B (en
Inventor
Stephen James
David J Rolands
Michael J Francis
Original Assignee
Wellcome Found
Mallinckrodt Veterinary Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88302656A external-priority patent/EP0284406B1/en
Priority claimed from GB888821076A external-priority patent/GB8821076D0/en
Application filed by Wellcome Found, Mallinckrodt Veterinary Ltd filed Critical Wellcome Found
Publication of LV10626A publication Critical patent/LV10626A/lv
Publication of LV10626B publication Critical patent/LV10626B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-93-540A 1988-03-25 1993-06-09 Peptides LV10626B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP88302656A EP0284406B1 (en) 1987-03-27 1988-03-25 Biologically active molecules
GB888821076A GB8821076D0 (en) 1988-09-08 1988-09-08 Peptides
PCT/GB1989/000311 WO1989009228A1 (en) 1988-03-25 1989-03-23 Peptides

Publications (2)

Publication Number Publication Date
LV10626A true LV10626A (lv) 1995-04-20
LV10626B LV10626B (en) 1995-10-20

Family

ID=26115951

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-540A LV10626B (en) 1988-03-25 1993-06-09 Peptides

Country Status (9)

Country Link
EP (1) EP0406316B1 (lv)
JP (1) JPH03503416A (lv)
AT (1) ATE117319T1 (lv)
AU (1) AU631350B2 (lv)
DE (1) DE68920735T2 (lv)
DK (1) DK230090D0 (lv)
HU (1) HU210966B (lv)
LV (1) LV10626B (lv)
WO (1) WO1989009228A1 (lv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
US6048538A (en) * 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
KR100639397B1 (ko) 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
CN109824775B (zh) * 2018-12-20 2021-02-09 中牧实业股份有限公司 ***a型武汉株单克隆抗体及其组合物与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699897A (en) * 1983-06-04 1987-10-13 Amgen Biologically active peptides structurally related to regions within growth hormones
US4558033A (en) * 1983-06-06 1985-12-10 Amgen Potentiation of the effects of insulin by peptides
GB8707398D0 (en) * 1987-03-27 1987-04-29 Coopers Animal Health Biologically active molecules

Also Published As

Publication number Publication date
HUT55413A (en) 1991-05-28
HU210966B (en) 1995-09-28
DK230090A (da) 1990-09-24
WO1989009228A1 (en) 1989-10-05
EP0406316A1 (en) 1991-01-09
DK230090D0 (da) 1990-09-24
HU892532D0 (en) 1991-03-28
AU631350B2 (en) 1992-11-26
ATE117319T1 (de) 1995-02-15
AU3417589A (en) 1989-10-16
JPH03503416A (ja) 1991-08-01
EP0406316B1 (en) 1995-01-18
DE68920735D1 (de) 1995-03-02
LV10626B (en) 1995-10-20
DE68920735T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
ATE110965T1 (de) Impfstoffe gegen hämophilus influenzae.
DK532184A (da) Antigene aminosyresekvenser
DE60117978D1 (de) Modifizierung des hepatitis b kernantigens
ES2002490A6 (es) Un metodo de preparar un virus recombinante
Brown et al. The use of acetylethyleneimine in the production of inactivated foot-and-mouth disease vaccines
ES2075440T3 (es) Vacuna contra la hepatitis b.
WO1993001210A3 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
FI910497A0 (fi) Nytt virus vid infektioes bursalsjukdom.
FI834590A (fi) Syntetisk picornavirus-antigen.
DK0755684T3 (da) Vaccinekonjugat
Dorset Detection of carp antibodies to spring viraemia of carp virus by a competitive immunoassay
LV10626A (lv) Peptidi
FI923020A (fi) Inte a inte b-sekvenser.
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
NO881661L (no) Humane rhinoviruspeptider.
ATE138078T1 (de) Analysemethode für infektiöse pferdeanämie-viren (eia-virus)
Lublin-Tennenbaum et al. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA
Joncas et al. Burkitt's lymphoma of the jaw in a Canadian child.
Smith et al. Reaginic Response in Rats to Alum Precipitated Antigens: II. Potentiation of the IgGa and IgE Responses to Dinitrophenylated Bovine γ-Globulin with Nippostrongylus brasiliensis
IL61278A0 (en) Specific antigen vaccine for tge in swine
SE8701294D0 (sv) Hiv-peptid
FI972658A (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
DE3475309D1 (en) Synthetic peptide, immune globulin and process for immunizing a mammal
RU96101231A (ru) Способ массового разведения dibrachys cavus walk "р-2"